Literature DB >> 16850987

Enhanced emission of nile red fluorescent nanoparticles embedded in hybrid sol-gel glasses.

Maria L Ferrer1, Francisco del Monte.   

Abstract

Highly fluorescent Nile Red (NR) nanoparticles embedded in a hybrid sol-gel glass are reported. The crystallite growth within the confined system created by the porous hybrid matrix results in NR nanoparticles of averaged dimensions below 36 nm. The preparation process allows for the control of both the conformation adopted by single NR molecules prior to aggregation (e.g., near planar) and the configuration of the aggregates (e.g., oblique with phi < 54.7 degrees) prior to their assembly in the supramolecular architecture which ultimately forms the nanoparticles. The full preservation of the fluorescent configuration of the aggregates in the nanoparticles is confirmed through the application of the exciton theory, and it is responsible for the significant increase of the fluorescence emission intensity (e.g., up to 525- and 70-fold as compared to that obtained for single NR molecules embedded in pure and hybrid silica glasses, respectively).

Entities:  

Year:  2005        PMID: 16850987     DOI: 10.1021/jp047550u

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  3 in total

1.  Spectral resolution of a second binding site for Nile Red on cytochrome P4503A4.

Authors:  Abhinav Nath; Cristina Fernández; Jed N Lampe; William M Atkins
Journal:  Arch Biochem Biophys       Date:  2008-03-25       Impact factor: 4.013

2.  Tunable size and spectral properties of fluorescent nanoGUMBOS in modified sodium deoxycholate hydrogels.

Authors:  Susmita Das; Sergio L de Rooy; Atiya N Jordan; Lin Chandler; Ioan I Negulescu; Bilal El-Zahab; Isiah M Warner
Journal:  Langmuir       Date:  2011-12-12       Impact factor: 3.882

3.  Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.

Authors:  Peisheng Xu; Emily Gullotti; Ling Tong; Christopher B Highley; Divya R Errabelli; Tayyaba Hasan; Ji-Xin Cheng; Daniel S Kohane; Yoon Yeo
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.